Old Web
English
Sign In
Acemap
>
authorDetail
>
Matthew P. Walker
Matthew P. Walker
Durham University
Epithelial sodium channel
Medicine
Pharmacology
Mucus
Cystic fibrosis
3
Papers
47
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
WS18.6 SPX-101 is a novel peptide-based therapeutic targeting ENaC that restores mucus transport
2017
Journal of Cystic Fibrosis
David W. Scott
Matthew P. Walker
Timothy J. Stuhlmiller
W. Bryant
J. Sesma
Juan R. Sabater
William M. Abraham
Robert Tarran
Show All
Source
Cite
Save
Citations (0)
SPX-101 Is a Novel Epithelial Sodium Channel–targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport
2017
American Journal of Respiratory and Critical Care Medicine
David W. Scott
Matthew P. Walker
Juliana I. Sesma
Bryant Wu
Timothy J. Stuhlmiller
Juan R. Sabater
William M. Abraham
Timothy M. Crowder
Dale J. Christensen
Robert Tarran
Show All
Source
Cite
Save
Citations (38)
Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosis.
2017
Inhalation Toxicology
Matthew P. Walker
Matt Cowlen
Dale J. Christensen
Mutsumi Miyamoto
Phillip Barley
Timothy M. Crowder
Show All
Source
Cite
Save
Citations (9)
1